{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98694",
      "recalling_firm": "Wells Pharma of Houston LLC",
      "address_1": "9265 Kirby Dr",
      "address_2": "",
      "postal_code": "77054-2520",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide.",
      "recall_number": "D-0505-2026",
      "product_description": "fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.",
      "product_quantity": "50  syringes",
      "reason_for_recall": "cGMP deviations.",
      "recall_initiation_date": "20260401",
      "center_classification_date": "20260428",
      "report_date": "20260506",
      "code_info": "Lot 011226204250063, Exp Date 05/14/2026",
      "more_code_info": ""
    }
  ]
}